Medinox, Inc. is a San Diego-based pharmaceutical company that is developing new small molecule drugs to treat a wide variety of unmet medical needs including
sepsis, arthritis & inflammation, diabetes and sickle cell anemia.
Medinox has been invited as a presenting company at the 2008 business forum of BIO 2008 in San Diego. The company will present the recent completed phase 1/2a clinical results of NOX-100 for treating septic shock patients conducted at 11 medical centers in the United States on June 17th at BIO 2008 in San Diego.